Attendee Quotations 2016

  • All presentations were of high quality, notably the clinical aspects of DDI (clinical relevance);
  • Nice spectrum from in vitro to in vivo, in silico, clinical perspective; Construction / design of sessions;

  • The FDA point of view on DDI was really an interesting topic; Food effects in drug development was also an important topic for me as well as the key prinicples presentations about fm and fu;

  • Very good ratio from presentations / discussions; bring together the various standpoints, medicine / PBPK moddeling, in vitro, industry;

  • All presentations were of high quality, notably the clinical aspects of DDI (clinical relevance);

  • As PBPK modeller, I found regulatory presentation & comments very useful as well as many discussion with participants;
  • There is a lot time for discussion; Many opportunities to interact with the rest of participants;

  • I enjoyed the opportunities for interaction between participants & speakers;